ArticleInfectious diseases and therapy2022
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
Joe Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.